Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 32 P365 | DOI: 10.1530/endoabs.32.P365

ECE2013 Poster Presentations Diabetes (151 abstracts)

Prediabetes in human immunodeficiency virus-infected patients: prevalence and clinical significance

Carolina García-Figueras 1 , Manuel Cayón 2 , Patricia Bancalero 1 & Alberto Terrón 1


1Infectious Diseases Unit, Hospital SAS, Jerez de la Frontera, Spain; 2Endocrinology and Nutrition Unit, Hospital SAS, Jerez de la Frontera, Spain.


Introduction: Although the importance of disorders in glucose metabolism is well recognized in human immunodeficiency virus (HIV) infected patients; the clinical relevance of prediabetes in this population has been little studied. The aims of this observational study were to determine the prevalence of prediabetes in a cohort of HIV-infected patients on long term highly active antiretroviral therapy (HAART) and to assess whether this condition involves the appearance of particular clinical and metabolic features.

Methods/design: One hundred and five HIV-positive individuals (85.7% men, mean age: 46±6.5 years) were enrolled. Prediabetes was defined using established ADA criteria. Data related to HIV infection, HCV co-infection and anthropometric and metabolic parameters were recorded. Fasting plasma glucose (FPG), fasting insulin levels and homeostatic model assessment-insulin resistance (HOMA-IR) were determined.

Results: Prevalence of prediabetes was higher (43.1%) among HCV/HIV as compared to 38.3% among those with HIV alone. When compared to normoglycemic controls, patients with prediabetes had significantly (P<0.05) higher waist-to-hip-ratio (0.96±0.1 vs 0.91±0.1); higher FPG levels (99.4±9.9 vs 90.4±9.6 mg/dl), higher basal insulin (14.1±11.5 vs 8.6±5.1 μIU/l) and higher HOMA-IR (4.4±0.9 vs 1.9±1.2). HCV/HIV with prediabetes were mostly men (100 vs 61%; P=0.001) and had significantly (P<0.001) lower LDLc levels (113.2±27.2 vs 139.9±37.7 mg/dl) and lower total cholesterol (180.41 ±34.7 vs 213.89±44.6 mg/dl) as compared to prediabetic HIV group. Although FPG levels and HOMA-IR were higher in prediabetic HCV/HIV patients, the difference was not significantly.

Conclusions: HIV patients on long-term HAART are at risk to develop prediabetes, especially if abdominal obesity is present thus, measurements of HOMA-index and waist-to-hip ratio should be routinely done. The worst lipidic profile in prediabetic HIV alone suggests that this parameter deserves special attention in these individuals.

Article tools

My recent searches

No recent searches.